PPHN
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) (NCT05527704) | Medical University of Warsaw | 2021-12-31 |
| Predictors of Inhaled Nitric Oxide Responsiveness in Patients With PPHN (NCT06043635) | Nationwide Children's Hospital | 2021-07-15 |
| Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn (NCT04328636) | Sohag University | 2017-11-01 |
| Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) (NCT01069861) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
Track PPHN automatically
Every clearance here is in the API, with alerts when new ones post.